Netherlands· NL-30266ca7714d

Loprox, hydrofiele crème 10 mg/g

A ciclopirox product containing ciclopiroxolamine, registered in Netherlands by Bipharma B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC D01AE14

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ciclopiroxolamineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ciclopirox is registered in 12 of 19 countries.

Countries holding a registration under ATC D01AE14 (ciclopirox), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search ciclopirox products by name

Ciclopirox · ATC D01AE14

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciclopirox costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from <$0.001 in Czechia to $2.04 in Switzerland — a ×4085 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ciclopirox · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$2.04
CZ Czechia<$0.001

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CICLOPIROXOLAMINE
Manufacturer: Bipharma B.V.
Country: Netherlands (NL)
ATC code: D01AE14
ATC class: Ciclopirox
Defined daily dose: 20 mg, T
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
15466

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

118 interactions on record for ciclopirox.

Graded by severity as the source publishes them — 118 info. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ciclopirox against other medicines How interaction checks work

Ciclopirox · interactions on record

118 records

118 info

Most severe, free to view

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Ciclopirox in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciclopirox products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Ciclocutan, Kitonail
Belgium · Myconail, Mycosten
Bulgaria · Батрафен, Микодефен
Cyprus · Kitonail, Mycomycen
Czechia · Polinail
Germany · Ciclocutan, Ciclopirox Acis
Denmark · Onytec
Estonia · Ciclopirox Auxilia
Spain · Ciclochem Uñas, Ciclocutan
Finland · Onytec
France · Ciclopirox Biogaran, Ciclopirox Substipharm
United Kingdom (Northern Ireland) · Onytec
Greece · Mycomycen
Croatia · Oxolam
Hungary · Batrafen, Kitolak
Ireland · Onytec
Italy · Carediesse, Niogermox
Lithuania · Onytec
Luxembourg · Mycoster
Latvia · Onytec
Norway · Onytec
Poland · Axopirox, Ciclolack
Portugal · Dexulac, Mycoster
Romania · Kitonail
Sweden · Onytec
Slovenia · Onytec
Slovakia · Polinaill

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f8776975-6a81-4092-98f1-daa59aee5401
GET /v1/drugs/f8776975-6a81-4092-98f1-daa59aee5401?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15466_smpc.pdf",
  "strength": null,
  "atc_label": "Ciclopirox",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15466",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CETYLALCOHOL",
    "MELKZUUR (L-,+ VORM) (E 270)",
    "MYRISTYLALCOHOL",
    "OCTYLDODECANOL",
    "PARAFFINE, DUNVLOEIBAAR (E 905)",
    "POLYSORBAAT 60 (E 435)",
    "SORBITANMONOSTEARAAT (E 491)",
    "STEARYLALCOHOL",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CICLOPIROXOLAMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15466.pdf",
  "authorised_at": "1993/03/17",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "15466",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ciclopirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console